Delta 9 Cannabis (TSX: DN) put out a news release this afternoon chock full of company updates. While typically a time for poor news to come out with today being Labour Day, the update was actually entirely positive in nature. Most significantly, Delta 9 announced that it intends to bring something to market that few other licensed producers have discussed – dry sift cannabis.
Delta 9 anticipates to bring a product line, known as “Sapphire” to the market in the third quarter of 2019. With an estimated price per gram of $30, the product is referred to as “dry sift cannabis” – also known traditionally as “kief” among cannabis users. With up to triple the potency of traditional cannabis flower, the product comes with a punch, yet no Canadian licensed producers have brought such a product to market. The product will be marketed exclusively to recreational users.
Little other details were provided on the matter.
Aside from the announcement of dry sift cannabis, Delta 9 also announced that it received its license to sell oils on Friday, for which it has already created two product lines for. “Odyssey” and “Oasis” are expected to be made available for both recreational and medical consumers in the near term.
The firm is also working on utilizing Nanosphere Health Sciences (CSE: NSHS) nanoparticle technology for the production of an intraoral cannabis oil product. Delta 9 is the exclusive licensee for the technology within Canada.
Delta 9 Cannabis recently announced its up-listing to the Toronto Stock Exchange, with the first trading day expected to occur tomorrow on September 3, 2019. The company closed at $0.91 on Friday on the TSX Venture Exchange.
Information for this briefing was found via Sedar and Delta 9 Cannabis. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
